Tilray Brands, Inc. Other Long-term Investments
Tilray Brands, Inc. (TLRY) had Other Long-term Investments of $13.39 million as of 2025-11-30, per its 10-Q filed 2026-01-08.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Long-Term Investments
us-gaap:OtherLongTermInvestments · last filed 2026-01-08
- 2025-11-30: Other Long-term Investments $13.39M.
- 2025-08-31: Other Long-term Investments $10.17M.
- 2025-05-31: Other Long-term Investments $10.13M.
- 2024-12-31: Other Long-term Investments $10.04M.
| Period end | Other Long-term Investments |
|---|---|
| 2025-11-30 | $13.39M 10-Q · filed 2026-01-08 |
| 2025-08-31 | $10.17M 10-Q · filed 2025-10-09 |
| 2025-05-31 | $10.13M 10-Q · filed 2026-01-08 |
| 2024-12-31 | $10.04M 10-Q · filed 2025-04-08 |
| 2024-11-30 | $7.42M 10-Q · filed 2025-01-10 |
| 2024-08-31 | $7.85M 10-Q · filed 2024-10-10 |
| 2024-05-31 | $7.86M 10-K · filed 2025-07-29 |
| 2024-02-29 | $8.06M 10-Q · filed 2024-04-09 |
| 2023-12-31 | $7.86M 10-Q · filed 2025-04-08 |
| 2023-11-30 | $8.03M 10-Q · filed 2024-01-09 |
| 2023-08-31 | $7.56M 10-Q · filed 2024-10-10 |
| 2023-05-31 | $7.79M 10-Q · filed 2024-10-10 |
| 2023-02-28 | $7.62M 10-Q · filed 2023-04-10 |
| 2022-11-30 | $8.21M 10-Q · filed 2023-01-09 |
| 2022-08-31 | $8.88M 10-Q · filed 2022-10-07 |
| 2022-05-31 | $10.05M 10-K · filed 2023-07-26 |
| 2022-03-31 | $10.05M 10-Q · filed 2023-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |